Paper884658
The effect of vincristine on methotrexate uptake and inhibition of DNA synthesis by human lymphoblastoid cells.
Warren RD and 2 others. Cancer Res, 1977. Cited by 33 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The effect of vincristine on methotrexate uptake and inhibition of DNA synthesis by human lymphoblastoid cells. Papers, record 884658. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/884658
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The effect of vincristine on methotrexate uptake and inhibition of DNA synthesis by human lymphoblastoid cells.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA | Major topic |
| Lymphocytes | Major topic |
| Methotrexate | Major topic |
| Vincristine | Major topic |
| Cell Line | |
| Deoxyuridine | |
| Drug Therapy, Combination | |
| Humans | |
| Leukemia |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31,691,080 | Coadministration of vindesine with high-dose methotrexate therapy increases acute kidney injury via BCRP, MRP2, and OAT1/OAT3. | Cancer Chemother Pharmacol | 2020 | https://conductscience.org/library/papers/31691080 | PubMed |
| 8,500,226 | Interactions of vinblastine and vincristine with methotrexate transport in isolated rat hepatocytes. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/8500226 | PubMed |
| 8,126,058 | Effects of hyaluronidase on doxorubicin penetration into squamous carcinoma multicellular tumor spheroids and its cell lethality. | J Cancer Res Clin Oncol | 1994 | https://conductscience.org/library/papers/8126058 | PubMed |
| 6,954,016 | Treatment of patients with refractory myelogenous leukemia with BCOMM[1,3-bis-chloro(2-chloroethyl)-1-nitrosourea (BCNU), oncovin (vincristine), cyclophosphamide, high-dose methotrexate and methyl-glyoxal bis-guanylhydrazone (MGBG)]. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/6954016 | PubMed |
| 3,719,898 | Methotrexate-vindesine association in head and neck cancer: modification of methotrexate's hydroxylation in presence of vindesine. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3719898 | PubMed |
| 292,535 | Vincristine-methotrexate combination chemotherapy and the influence of weight loss on experimental tumour growth. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/292535 | PubMed |
| 78,795 | Antineoplastic drugs: clinical pharmacology and therapeutic use. | Drugs | 1978 | https://conductscience.org/library/papers/78795 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/884658
GET https://conductscience.org/api/papers/v1/884658/authors